Author
Koç UniversityORCID 0000-0002-1410-2898Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Göktuğ Karabiyik, Ozlem Yedier-Bayram, Feridun Aksu…·Tugba Bagci Onder
This study identifies CBP/p300 inhibition as a strategy to overcome vincristine resistance in medulloblastoma by targeting genes involved in drug resistance.
Feridun Aksu, Buse Cevatemre, Nareg Pinarbasi Degirmenci…·Tugba Bagci Onder
The paper identifies HDAC6 as an epigenetic vulnerability in TMZ-resistant glioblastoma models and shows HDAC6 inhibitors can restore TMZ sensitivity.
Ezgi Yağmur Kala, Filiz Senbabaoglu Aksu, Muhammed Erdem Ercan…·Tugba Bagci Onder
This study identifies RBBP4 as a critical regulator of cell cycle progression in TMZ-resistant glioblastoma through CRISPR screens and functional analyses.
Lucia Cottone, James E. Dunford, Eleanor Calcutt…·Adam P. Cribbs
This study identifies ATF4-mediated metabolic stress response as a therapeutic target in chordoma, showing that EPRS inhibitors reduce cell viability and inhibit tumor growth in vivo.